Previous 10 | Next 10 |
Abiomed (NASDAQ: ABMD ) is scheduled to announce Q3 earnings results on Thursday, February 6th, before market open. The consensus EPS Estimate is $1.09 (+12.4% Y/Y) and the consensus Revenue Estimate is $226.92M (+13.1% Y/Y). Over the last 2 years, ABMD has beaten EPS estimates ...
January 28, 2020 Palm Beach, FL – January 28, 2020 – Augmented reality is having a profound impact on the healthcare industry, especially medical training. Not only can it bring 3D anatomical learning to life, as noted by medical device company, Proximie ,...
Abiomed (NASDAQ: ABMD) , a maker of heart pumps for use during medical procedures, had a difficult 2019. The stock fell 48%, earnings missed analysts' estimates after three quarters of positive surprises, and the company recently slashed its outlook for the full year. While all of this may so...
The following slide deck was published by Abiomed, Inc. in conjunction with this Read more ...
Abiomed ( ABMD -12.9% ) slips to three-month lows after issuing below consensus revenue guidance for both FQ3 and FY 2020. More news on: Abiomed, Inc., Healthcare stocks news, Stocks on the move, Read more ...
Acasti Pharma (NASDAQ: ACST ) -66% after unsuccessful results from a Phase 3 TRILOGY 1 trial. More news on: Acasti Pharma Inc., Stage Stores, Inc., Five Below, Inc., Stocks on the move, Read more ...
Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies today reported preliminary, unaudited, third quarter fiscal 2020 revenue of approximately $221.6 million, an increase of 10% compared to revenue of $200.6 million for the same period of fiscal 2019. ...
This list is a snapshot of the best healthcare stocks for an entire decade, from 2010 to 2020. As such, some magnificent stocks are excluded, simply because of the measurement period. For instance, Axsome Therapeutics had an amazing 3,578% return in 2019. And yet Axsome's fantastic 2019 r...
Historically, These Geopolitical Actions Don’t Cause Extended Sales These are the times that the cash I have been bugging you to create is going to come in very handy. That slug of cash, hopefully, 25% of your trading budget, can now be deployed to take advantage. I would advise n...
Leaders More news on: Apple Inc., Microsoft Corporation, JPMorgan Chase & Co., Top stock market news, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Abiomed (Nasdaq: ABMD) announces the United States Food and Drug Administration (FDA) has approved the version of Impella ECP that will be used in the Impella ECP Pivotal Trial, and the first two patients have been enrolled in the trial. Amir Kaki, MD, director of mechanical circulatory support...
Steel Dynamics Set to Join S&P 500; Super Micro Computer to Join S&P MidCap 400 Steel Dynamics Set to Join S&P 500; Super Micro Computer to Join S&P MidCap 400 PR Newswire NEW YORK , Dec. 19, 2022 /PRNewswire/ -- S&P MidCap 400 constituent...
Abiomed (Nasdaq: ABMD) announces the first three patients in the world have been treated with Impella RP Flex with SmartAssist, Abiomed’s newest heart pump for patients experiencing right heart failure. All three patients have now been successfully weaned off Impella support and two have...